Protein C (PC) is activated on the surface of endothelial cells by the thrombin-thrombomodulin complex and the generated activated PC (APC) inhibits blood coagulation by down regulating prothrombin activation in a negative feedback loop. In addition to its role as an anticoagulant, APC has major anti-inflammatory effects that led to its recent approval for treatment of patients with severe sepsis. The molecular basis for APC's important protective effects is incompletely understood. This application is based upon our recent identification of protease-activated receptor 1 (PAR1) and endothelial cell PC receptor (EPCR) as part of a novel APC signaling pathway in endothelial cells. The general hypothesis is that PARl-dependent signaling of the PC system in endothelial cells limits inflammatory responses and reduces lethality in sepsis. PAR1 can be efficiently activated by thrombin and Aim#1 is to define how autocrine PAR1 signaling by APC is linked to PC activation on the cell surface. Experiments will analyze whether activation of EPCR-bound PC by thrombin-thrombomodulin leads to enhanced APC signaling and what the role of membrane compartmentalization of PC pathway components and PAR1 is.
Aim#2 is to define the role of PAR1, EPCR, and thrombomodulin in APC-dependent effects on gene expression, including the down regulation of genes involved in inflammatory and apoptotic pathways in activated endothelial cells. Micro array analysis will identify downstream targets of protective PC pathway signaling and adenovirus-mediated expression of mutant EPCR and thrombomodulin will define the roles of these cofactors.
Aim#3 is to demonstrate an in vivo role of PAR1 activation by the PC pathway. Transgenic mice will be generated with endothelial cell-specific expression of either wild type PAR1 or a variant PAR1 that can be activated by APC but not thrombin. Effects of APC administration on inflammatory responses and lethality in a model of septicemia will be analyzed in the mice and the results are expected to define the role of endothelial PAR1 in systemic inflammation and in mediating protective effects of APC.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL073318-01
Application #
6605404
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Link, Rebecca P
Project Start
2003-08-01
Project End
2007-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
1
Fiscal Year
2003
Total Cost
$422,325
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Schuepbach, R A; Madon, J; Ender, M et al. (2012) Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects. J Thromb Haemost 10:1675-84
Schuepbach, Reto A; Velez, Kara; Riewald, Matthias (2011) Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain. Blood 117:6338-46
Schuepbach, R A; Riewald, M (2010) Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor. J Thromb Haemost 8:379-88
Mosnier, Laurent O; Zampolli, Antonella; Kerschen, Edward J et al. (2009) Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood 113:5970-8
Schuepbach, Reto A; Feistritzer, Clemens; Fernández, José A et al. (2009) Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost 101:724-33
Schuepbach, Reto A; Feistritzer, Clemens; Brass, Lawrence F et al. (2008) Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin. Blood 111:2667-73
Feistritzer, Clemens; Riewald, Matthias (2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105:3178-84
Feistritzer, C; Lenta, R; Riewald, M (2005) Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling. J Thromb Haemost 3:2798-805